RABISIN MULTI, injekcinė suspensija
RABISIN MULTI, injekcinė suspensija
Authorised
- Rabies virus, strain G52, Inactivated
Product identification
Medicine name:
RABISIN MULTI, injekcinė suspensija
Active substance:
- Rabies virus, strain G52, Inactivated
Target species:
-
Dog
-
Cat
-
Cattle
-
Sheep
-
Ferret
-
Horse
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Product details
Active substance and strength:
-
Rabies virus, strain G52, Inactivated1.00international unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Cat
-
Cattle
-
Meat and offal0day
-
Milk0day
-
-
Sheep
-
Meat and offal0day
-
Milk0day
-
-
Ferret
-
-
Intramuscular use
-
Dog
-
Cat
-
Horse
-
Meat and offal0day
-
-
Cattle
-
Meat and offal0day
-
Milk0day
-
-
Sheep
-
Meat and offal0day
-
Milk0day
-
-
Ferret
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/11/2029/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
RV2029.pdf
Lithuanian (PDF)
Download Published on: 28/06/2022
How useful was this page?: